Kalaris Therapeutics, Inc.

Kalaris Therapeutics, Inc.

NNASDAQ:KLRS
1.43
USD
-0.03
(-2.05%)
-1.84EPS
68.80MMarket Cap
Mar 23Next Earn

Kalaris Therapeutics, Inc. Documents

Q1 FY2026 · Quarterly report

May 12, 2026 · 144 pages

Read Kalaris Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this quarterly report
Create a free account to start reading

Full documents are included with Professional

Q1 FY2026 documents